Then we overexpressed or silenced SVIL‐AS1 in MCF‐10A AKT1E17K, IHH4 (papillary thyroid carcinoma cell), and KU‐19‐19 (bladder carcinoma cell), which all had the AKT1E17K mutation (Figure 2C,F). This evidence concerns the gene SVIL and thyroid gland papillary carcinoma.